316 related articles for article (PubMed ID: 1602389)
1. Comparison of the serotonin receptors that mediate smooth muscle contraction in canine and porcine coronary artery.
Cushing DJ; Cohen ML
J Pharmacol Exp Ther; 1992 Jun; 261(3):856-62. PubMed ID: 1602389
[TBL] [Abstract][Full Text] [Related]
2. Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
Cushing DJ; Cohen ML
J Pharmacol Exp Ther; 1993 Jan; 264(1):193-200. PubMed ID: 8423526
[TBL] [Abstract][Full Text] [Related]
3. LY215840, a high-affinity 5-HT7 receptor ligand, blocks serotonin-induced relaxation in canine coronary artery.
Cushing DJ; Zgombick JM; Nelson DL; Cohen ML
J Pharmacol Exp Ther; 1996 Jun; 277(3):1560-6. PubMed ID: 8667223
[TBL] [Abstract][Full Text] [Related]
4. Serotonin-induced relaxation in canine coronary artery smooth muscle.
Cushing DJ; Cohen ML
J Pharmacol Exp Ther; 1992 Oct; 263(1):123-9. PubMed ID: 1403777
[TBL] [Abstract][Full Text] [Related]
5. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
Germonpré PR; Joos GF; Pauwels RA
Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
[TBL] [Abstract][Full Text] [Related]
6. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
[TBL] [Abstract][Full Text] [Related]
7. Characterization of serotonin receptors in isolated rat intramyocardial coronary artery.
Lai FM; Tanikella T; Cervoni P
J Pharmacol Exp Ther; 1991 Jan; 256(1):164-8. PubMed ID: 1988655
[TBL] [Abstract][Full Text] [Related]
8. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
Cohen ML; Schenck KW; Kurz KD
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat.
Watts SW; Thompson JM
J Pharmacol Exp Ther; 2004 Apr; 309(1):165-72. PubMed ID: 14724222
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of the 5-HT receptors mediating contraction and relaxation of canine isolated proximal stomach smooth muscle.
Janssen P; Prins NH; Meulemans AL; Lefebvre RA
Br J Pharmacol; 2002 May; 136(2):321-9. PubMed ID: 12010782
[TBL] [Abstract][Full Text] [Related]
11. Relationship between receptors mediating serotonin (5-HT) contractions in the canine basilar artery to 5-HT1, 5-HT2 and rat stomach fundus 5-HT receptors.
Cohen ML; Colbert WE
J Pharmacol Exp Ther; 1986 Jun; 237(3):713-8. PubMed ID: 3712277
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the contraction to 5-HT in the canine colon longitudinal muscle.
Prins NH; Briejer MR; Schuurkes JA
Br J Pharmacol; 1997 Feb; 120(4):714-20. PubMed ID: 9051313
[TBL] [Abstract][Full Text] [Related]
13. 5-HT1B receptor-mediated contractions in human temporal artery: evidence from selective antagonists and 5-HT receptor mRNA expression.
Verheggen R; Hundeshagen AG; Brown AM; Schindler M; Kaumann AJ
Br J Pharmacol; 1998 Aug; 124(7):1345-54. PubMed ID: 9723944
[TBL] [Abstract][Full Text] [Related]
14. Participation of 5-HT1-like and 5-HT2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs.
Verheggen R; Freudenthaler S; Meyer-Dulheuer F; Kaumann AJ
Br J Pharmacol; 1996 Jan; 117(2):283-92. PubMed ID: 8789380
[TBL] [Abstract][Full Text] [Related]
15. LY215840, a potent 5-hydroxytryptamine (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2 receptors and delays occlusion in a rabbit model of thrombosis.
Cohen ML; Robertson DW; Bloomquist WE; Wilson HC
J Pharmacol Exp Ther; 1992 Apr; 261(1):202-8. PubMed ID: 1560366
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
Hamel E; Robert JP; Young AR; MacKenzie ET
J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950
[TBL] [Abstract][Full Text] [Related]
17. LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat.
Cohen ML; Fuller RW; Kurz KD
J Pharmacol Exp Ther; 1983 Nov; 227(2):327-32. PubMed ID: 6313898
[TBL] [Abstract][Full Text] [Related]
18. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
Kemp BK; Cocks TM
Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
[TBL] [Abstract][Full Text] [Related]
19. Evidence for two populations of 5-hydroxytryptamine receptors in dog basilar artery.
Frenken M
J Pharmacol Exp Ther; 1989 Jul; 250(1):379-87. PubMed ID: 2545865
[TBL] [Abstract][Full Text] [Related]
20. Naturally occurring clavines: antagonism/partial agonism at 5-HT2A receptors and antagonism at alpha 1-adrenoceptors in blood vessels.
Pertz H
Planta Med; 1996 Oct; 62(5):387-92. PubMed ID: 8923801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
